SCHEMBL8323332

SCHEMBL8323332

N#C/C(=C/c1cc(O)c(O)c(Br)c1)S(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.58
PKM P14618 3/20 0.49
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MEN1 O00255 2/20 0.49
KDM4E B2RXH2 2/20 0.49
POLB P06746 1/20 0.49
GAA P10253 1/20 0.49
ALPG P10696 1/20 0.49
ALOX15 P16050 1/20 0.49
ALOX12 P18054 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
ERBB2 P04626 1/20 0.39
CA1 P00915 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8323329 1.00 EGFR (0.58) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL9231430 1.00 EGFR (0.58) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7962343 0.88 EGFR (0.62) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7962335 0.88 EGFR (0.62) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7962340 0.88 EGFR (0.62) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7952009 0.88 IGF1R (0.51) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7952007 0.88 IGF1R (0.51) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7952006 0.88 IGF1R (0.51) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7965455 0.84 KDM4E (0.70) EGFRPKMKMT2AALDH1A1HPGD
SCHEMBL7965453 0.84 KDM4E (0.70) EGFRPKMKMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed